S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|CTI BioPharma Announces Presentation of Data Demonstrating Pacritinib Overrides Stromal Mediated Resistance in FLT3-ITD Positive AML Cells (2014/12/9)|
|Exelixis’ Collaborator Genentech Files New Drug Application for the Combination of Cobimetinib and Vemurafenib for the Treatment of Patients With BRAF V600 Mutation-Positive Advanced Melanoma (2014/12/15)|
|Exelixis Announces Acceptance of New Drug Application for Cobimetinib in Combination with Vemurafenib for Treatment of Patients with BRAF V600 Mutation-Positive Advanced Melanoma (2015/2/19)|
|Array Announces Agreement To Acquire ENCORAFENIB (LGX818) (2015/1/23)|
|Exelixis and Swedish Orphan Biovitrum AB (Sobi) Extend and Restructure Distribution Agreement for COMETRIQ® for Medullary Thyroid Cancer (2015/1/7)|
|CTI BioPharma Announces 2015 Outlook and Recent Drug Portfolio Progress (2015/1/8)|
|Clinical Study Results Presented at the 2015 Gastrointestinal Cancer Symposium Support Utility of Trovagene's Precision Cancer Monitoring Platform in Colorectal and Pancreatic Cancer Patients (2015/1/20)|
|Exelixis to Release Fourth Quarter and Full Year 2014 Financial Results on Tuesday, February 24, 2015 (2015/2/2)|
|Exelixis to Present at the Leerink Global Healthcare Conference on Wednesday, February 11 (2015/1/29)|
|Exelixis Announces Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update (2015/2/24)|
Click above to view more mutual fund data and stats for mek - Metals Creek Resources Corp.